Panax ginseng shows highest effectiveness in treating Alzheimer's. Learn more about AVXL's blarcamesine and SAVA's simufilam ...

Ann Lange was diagnosed with Alzheimer's in 2015, but with the help of clinical trials her disease has not progressed past ...

Researchers map the unique genetic regulation of proteins in human cerebrospinal fluid, identifying potential targets for ...

Such an "exercise-in-a-pill" treatment could benefit older people, who may have trouble achieving recommended levels of ...

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of ...

Annovis Bio, Inc. (NYSE: ANVS) announced its financial results for the third quarter ending September 30, 2024, alongside ...

An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

Kisunla will join lecanemab as an option for the treatment in Japan of early symptomatic Alzheimer's disease. Lecanemab was ...

Researchers have developed a promising nasal spray therapy targeting neuroinflammation in Alzheimer’s disease, potentially ...

Recent research has revealed that alcohol use disorder and Alzheimer’s disease share significant patterns of gene ...